logo
Plus   Neg
Share
Email
Comment

Shire To Buy FerroKin BioSciences For $100 Mln Plus Milestone Payments

Shire plc (SHP.L,SHPGY) Thursday reported agreeing to acquire privately-held FerroKin Biosciences Inc. for a cash consideration of $100 million and milestone payments of up to $225 million. The purchase is expected to add the iron chelator FBS0701, which is seen as a possible treatment for transfusional iron overload to Shire's hematology portfolio.

While phase 2 trials of FBS0701 are currently underway, Shire sees additional trials as well as a global filing for indications of Myelodysplastic Syndrome and hemoglobinopathies, with a launch target of 2016. Further, such key FerroKin employees as Founder and CEO Hugh Rienhoff may provide consulting services during a transition period.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of BHP Billiton plc were losing around 4 percent in the morning trading in London after the Anglo-Australian mining giant reported Tuesday sharply lower profit in its first half on US tax charge, despite higher revenues. Further, the company announced higher dividend, but trimmed its forecast for Group copper equivalent volume growth for fiscal 2018. Asia-focused lender HSBC Holdings Plc reported late Monday a significant growth in fiscal 2017 profit, reflecting higher revenues and the absence of loss related to Brazil operations. The company noted that all of its global businesses grew adjusted profits and three main global businesses generated improved adjusted revenue. Further, the company maintained its dividend. Tech giants Amazon.com, YouTube and Twitter as well as Verizon Communications are exploring bids for digital streaming rights to the National Football League or NFL's Thursday Night Football package, according to media reports. The NFL is likely to strike a multi-year deal for the digital streaming rights. However, the television audience for the NFL has declined for two consecutive years.
comments powered by Disqus
Follow RTT